It has
been nearly a month since I penned the previous article in this seemingly endless
series about Kava, the rather wondrous plant from the South Pacific, the extract
from whose roots, in medicinal form, have become increasingly popular in Europe
and the US over the last decade as a natural antidote to combat stress, anxiety
and tension. Readers will have to refer back to the previous five articles on
kava in this newsletter, and will note that there recently seems to be almost
a worldwide 'ban' (except in the South Pacific) on sales of medicinal extract
and tablets of kava in Europe, the US, Canada and Australia. We have gone into
the pros and cons of this in the past articles and the reasons why we think
this 'ban' is wrong and mistaken. The evidence but forward by German medical
authorities indicating a possible connection between medicinal kava intake and
liver damage does not seem to be conclusive nor of good quality (although, of
course, the medical authorities have done the correct thing by bringing any
suspected health threat to notice), and yet other countries have taken these
warnings at face value with almost no enquiry and have recommended the withdrawal
of medicinal kava and tablets from pharmacy shelves. This 'problem' really came
to public notice in Germany from the end of last year and newspaper reports
fanned the flames of a 'kava panic' in Germany where kava medicinal extract
and tablets sales have been massive over the last decade or more, and particularly
from the late 1990s. Newspaper reports spreading out from Germany around the
world have, in effect, had the unfortunate result of destroying the important
kava export market from the South Pacific, causing puzzlement, anger and hardship
in certain Pacific Island nations. Everyone in the pacific now believes that
kava extracts are completely banned throughout Europe. But this is not the case.
Although, as we pointed out, kava extract was officially banned in France from
mid-January, the only country in Europe now where it is easily, openly and officially
available from pharmacies as before is Germany, the country which seemed to
have begun the whole furore in the first place. I confirmed this again by phoning
contacts in Germany on April the 29th and was told the pharmacies
were selling kava tablets as before, although sales were lower than before the
press furore, and that the relevant German government ministry (the Bf Arm,
the Federal Institute of Drugs and Medicinal Devices, in Bonn) had not made
any announcement, in spite of what the world seems to think.
So why
all the problems? Why can't people elsewhere in Europe get kava tablets if they
want to and what has led to this situation where most people assume there is
a 'ban' when there isn't (except in France). It has an awful lot do with the
way the press has dealt with this affair over the last six months and is almost
an accident of timing combined with other rather dubious trends happening in
the medical and pharmaceutical world of Europe and the US at the moment.
In
August 2001, at the height of a major medical scandal, the German government
forced the withdrawal from use of the cholesterol-reducing drug Lipobay (called
Baycol in the US) produced by the Bayer Company. This particular drug (nothing
whatsoever to do with kava) had been widely promoted and sold and was then found
to have major side effects which it seems had possibly been known for some time.
By mid - January 2002 even the Bayer company was forced to admit that the drug
had been responsible for an estimated 100 deaths worldwide (from renal failure,
etc), and it seems that over 1000 patients taking it may have been potentially
crippled. In the middle of 2001, though, the scandal was at its height in Germany,
and journalists dug out rather horrifying information regarding certain activities
of the Bayer Company and certain German doctors in regard to this medicine.
At one time it looked as if the resulting furor and potential court cases, some
said, might bankrupt the company. German press reports indicated that the Bayer
company was alleged to have 'sweetened' (some said 'bribed') certain doctors
in Germany to persuade them to prescribe the anti-cholesterol drug: the return
for prescription was said to be a luxury trip on the Orient Express. This was
said to be happening from spring of 1999. Doctors were to use copies of the
prescription forms to show to Bayer that they had put patients on to the drug,
and with every 25 patients the prescribing doctor was promised one of these
trips. When this 'arrangement' came out in the press, Bayer countered by saying
the luxury trips were only an "information event for southern German doctors".
Of course there was a press frenzy, and rightly so. Information about possibly
slightly dubious arrangements between certain pharmaceutical/drug companies
and certain sections of the medical profession (not just within Germany but
almost worldwide) has been seeping out for years, and this was just confirmation
to certain journalists of what some saw as a wider phenomenon. This led the
ex-President of the Berlin Medical Practitioners' Board to state that often
doctors' training costs or their medical journals were frequently paid for by
elements of the pharmaceutical industry. Whether he said this in their defence,
to show that such links were normal practice, I am not sure. Almost the last
straw for the Bayer company came in the middle of 2001 when it was discovered
that a medical study done for the German Health Ministry, dated 15th
June 2001 and indicating serious side-effects with the Lipobay drug, was held
on to by Bayer and only passed on by the company to the relevant government
ministry at the beginning of August 2001, after government withdrawal of the
drug.
This affair
'went international', with the use in the US of the same drug, there called
Baycol. It seems the potential court cases in the US are still piling up. At
the same time, however, in the US, another series of medical-associated scandals
were reaching their climax. For a number of years it had been suspected that
certain drug firms might have been trying to assert undue influence on certain
medical journals to get positive reports about their new drugs published or
to get adverse studies dropped from publication. This came to a head in the
US in early September 2001 when representatives of a dozen of the world's most
prestigious medical journals announced the adoption of strict uniform requirements
to prevent drug firms that fund studies from manipulating the results or burying
the publication of studies that are unfavourable. This move was to stop the
growing influence exerted by drug firms over research findings, and was the
result of several major related scandals of this type over the last decade.
Knowledgeable journalists in Europe and the US moved in on this series of affairs,
producing articles with headlines such as 'Drug scientists put profits before
lives'. For those with knowledge of some of the seamier aspects of this drug/medical
world, this was nothing new, but it was rather new for most of the reading public.
There have always been suspicions that certain companies might use rather wily
tactics to not just get their new medicines/drugs approved, but also might use
other wily tactics to get certain doctors or government ministries to promote
them. This was put very well by Australian grief counsellor, Mal McKissok, in
an article in the 'Sydney Morning Herald' on the 4th March 2002:"
I think there's a conflict of interest when drug companies are sponsoring research
and governments are responding to it". Well, there is not just a potential
conflict of interest but a potential situation of danger for the public!
Readers
should therefore view the press furore last year about kava with all the above
in mind: the Bayer company scandal was winding down as was that related to publication
of medical results, but the public and journalists were still 'primed', so to
speak. And it is at just that precise time that a mention about Kava and possible
connection with liver damage came to public notice. The media juggernaut, sensing
another major news item, shifted into high gear. Medical authorities, terrified
of the (health and) financial ramifications of the Lipobay/Bayer company affair,
almost immediately started issuing cautionary warnings and the whole thing began
to spiral almost out of control with hardly anyone really bothering to look
in depth at the basis of the claims. Kava was damned in the public eye before
it even had a chance to speak up for itself. Although an acetone-based kava
extract ('Laitan') had been pulled off the market in Switzerland as early as
October 2000, there was no associated media build-up as the incident was minor,
unproved, a precaution, and the media were interested in other things at the
time. It was really only from September 2001, as the other above-mentioned scandals
started winding down, when a few minor medical reports about kava came to the
notice of the German press, that the media there really began to move into action.
No one was really there to protect kava at her time of need from the increasing
barrage of insults. In January 2002, when my wife and I were in Germany and
I was speaking to pharmaceutical people all over Germany by phone to try and
get to the bottom of all this, no-one I spoke to thought that the 24 cases of
liver damage mentioned by the German Bf ArM in their circular letter of 8th
November 2001 had anything really to do with kava extract, it just so happened
that kava extract intake was one of the ingredients shared by these 24 individuals.
There were, of course, thousands of other cases of liver damage within Germany
over the same time period, but kava was not blamed for these. The most serious
cases were one death (politely called 'Exitus' in some of the reports) from
liver failure, and four, possibly five, liver transplants. When one actually
looks at the German list, it looks 'set in concrete' and all set and sealed.
But it is not. The sad but famous 'Exitus' case, if one follows up to find out
who it actually was (there is, of course, no information in the list), turns
out to have been that of an 81 year-old woman with a long history of alcohol
abuse and possible other substances (I got this information over the phone)
who had also been taking 120mg/day of an ethanol-based kava extract over a 9-month
period. Half of the 24 listed cases were people over 60.Long-term alcohol use
was thought to be common denominator in many of the cases. This rather ties
in with a general Ibicenco belief that all Germans really seem to do is work,
get drunk, and sleep.
This rather
reminds me of a rather interesting 'joke' from Vanuatu, in the Southwest Pacific,
the homeland of the real kava. There, death is not really looked upon, as something
natural unless one is extremely old and one passes away in a style that is obviously
natural. Most other deaths - of individuals not of a proper age to die naturally
- is attributed to sorcery, poisoning, or other such causes: i.e., someone else
is involved. One old Vanuatu friend told me years ago the following example:
'Well, what if you are 100 years old, blind, deaf and crippled and walking with
the help of two sticks below a 100-foot high cliff during an earthquake and
a cyclone and a rock falls on you and kills you? Is that a natural death or
did someone make the rock fall?' There was a certain amount of traditional Vanuatu
poetic license (there called 'putting sixpence on top') in that quote, but it
does, I believe, have relevance for these above suspected kava-associated liver
damage cases in Germany. Kava seems to have been chosen as 'the rock'! And why
would this be? More next week. |